- 4009 Hackney Springs Ln, Sachse, TX 75048
Master Delaware Medicaid, Medicare, Highmark Blue Cross Blue Shield Delaware & 75+ Commercial Payer Requirements
Slash Claim Denials by 35% with CPT/HCPCS Code Precision
Navigate Delaware's Concentrated Payer Market and MCO Requirements
Post Payments in 24-48 Hours—Zero Revenue Bottlenecks
Recover Outstanding A/R in 30 Days—42% Faster Than Industry Average
Highmark Blue Cross Blue Shield dominates Delaware with 70% market share, creating intense pressure on reimbursement rates and strict medical necessity requirements. A payer relationship failure impacts 70-80% of commercial revenue.
First-pass clean claim rates of 98%
Denial rates below 3%
Days in A/R reduced from 78+ days to under 21 days
Overall revenue improvement of 8-12%
Denials reduced by 35%
Complete payer enrollment, CLIA certification management, and network participation setup across all insurance carriers. TransLabs manages every credentialing detail so that your laboratory gets paid in-network from day one without any administrative delays.
Real-time insurance verification, benefits investigation, and prior auth completed before specimen processing begins. Confirming coverage upfront eliminates preventable denials and protects your lab from unexpected reimbursement failures.
Patient registration, appointment coordination, insurance verification, and customer service excellence managed by experienced laboratory billing professionals. A well-run front office reduces downstream billing errors and creates a better experience.
TransLabs specializes exclusively in Delaware laboratory facilities, giving us unmatched expertise in Delaware Medicaid MCO requirements, Highmark BCBS Delaware policies, Medicare Administrative Contractor (MAC) Jurisdiction L (JL) requirements, multi-state patient coordination, and Delaware-specific payer regulations. Our 98% first-pass clean claim rate and 99% client retention rate reflect our commitment to excellence.
The top five denial reasons are:
A Local Coverage Determination (LCD) is a Medicare policy that defines which tests are covered, which ICD-10 codes support medical necessity, and testing frequency limitations. Delaware falls under Medicare Administrative Contractor (MAC) Jurisdiction L (JL), administered by Novitas Solutions, which has strict LCDs for molecular and genetic testing. Billing a test with a non-covered diagnosis code results in automatic denial and potential audit exposure.
We pre-verify medical necessity before testing, submit prior authorizations with comprehensive documentation to the appropriate Delaware Medicaid MCO or commercial payer, use LCD-compliant diagnosis coding, attach required medical records, and proactively communicate with payers to prevent denials. We maintain specialized expertise in Highmark BCBS Delaware’s requirements given their market dominance. For denied claims, we submit detailed appeals with peer-reviewed literature and clinical guidelines. Our molecular/genetic testing claim acceptance rate is 98%.
